Hedgehog signaling pathway antagonist cancer treatment

作者: Max Wicha , Gabriela Dontu , Suling Liu

DOI:

关键词:

摘要: The present invention provides methods and compositions for treating tumorigenic cells (e.g., mammary progenitor cancer cells), with hedgehog signaling pathway antagonists Cyclopamine or analogs thereof), as well screening their ability serve anti-neoplastic agents capable of killing cells. identifying based on increased expression a component (e.g. PTCHl, Dih, GUI, Bmi-1, VEGF), obtaining enriched populations cells, causing to proliferate and/or differentiate.

参考文章(91)
Eric Lagasse, Timothy Austin, Liver engrafting cells, assays, and uses thereof ,(2002)
Michelle Aszterbaum, Jeannette M. Bonifas, Levy Kopelovich, Ervin H. Epstein, Zhilan Hu, Mark A. Israel, Shoichiro Ohta, David R. Bickers, Yu Liang, Geraldine Aragon, Evidence for lack of enhanced hedgehog target gene expression in common extracutaneous tumors. Cancer Research. ,vol. 63, pp. 923- 928 ,(2003)
Douglas A. Holtzman, Thomas M. Barnes, Charles R. Mackay, Sean A. McCarthy, Yang Pan, Samantha J. Busfield, David P. Gearing, Jose M. Lora, Delta3, FTHMA-070, Tango85, Tango77, SPOIL,NEOKINE, Tango129 and integrin alpha subunit protein and nucleic acid molecules and uses thereof ,(2007)
David R. Crockford, Buck A. Rhodes, Method and composition for cancer detection in humans ,(1979)
Andrew Madin, Mark Peter Ridgill, Joanne Clare Hannam, Ian James Collins, Gamma-secretase inhibitors ,(2001)
Michele Sanicola-Nadel, Leona E. Ling, Angiogenesis-modulating compositions and uses ,(2001)
Gavin Thurston, Irene Noguera, Nicholas Gale, DII4 antagonists, assays, and therapeutic methods thereof ,(2005)